Healthcare provider profile · identity verified

Paula A Cole, APN

Nurse Practitioner · WAYNESBORO, TN · NPI 1649202953

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	297	49
Rosuvastatin Calcium	Rosuvastatin Calcium	273	74
Pantoprazole Sodium	Pantoprazole Sodium	242	61
Gabapentin	Gabapentin	235	42
Lisinopril	Lisinopril	231	61
Amlodipine Besylate	Amlodipine Besylate	205	54
Omeprazole	Omeprazole	188	45
Levothyroxine Sodium	Levothyroxine Sodium	187	48
Meloxicam	Meloxicam	178	53
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	158	42
Metformin Hcl	Metformin Hcl	158	45
Atorvastatin Calcium	Atorvastatin Calcium	156	48
Azithromycin	Azithromycin	156	110
Montelukast Sodium	Montelukast Sodium	142	31
Potassium Chloride	Potassium Chloride	140	37
Escitalopram Oxalate	Escitalopram Oxalate	139	39
Trazodone Hcl	Trazodone Hcl	113	23
Hydrochlorothiazide	Hydrochlorothiazide	112	28
Lorazepam	Lorazepam	106	21
Clonazepam	Clonazepam	100	suppressed
Alprazolam	Alprazolam	84	13
Famotidine	Famotidine	76	23
Metoprolol Succinate	Metoprolol Succinate	75	18
Citalopram Hbr	Citalopram Hydrobromide	73	18
Losartan Potassium	Losartan Potassium	73	24
Furosemide	Furosemide	71	26
Sertraline Hcl	Sertraline Hcl	70	17
Fenofibrate	Fenofibrate Nanocrystallized	68	21
Alendronate Sodium	Alendronate Sodium	64	22
Glipizide	Glipizide	64	18
Esomeprazole Magnesium	Esomeprazole Magnesium	59	suppressed
Buspirone Hcl	Buspirone Hcl	56	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	14
Methylprednisolone	Methylprednisolone	56	40
Simvastatin	Simvastatin	56	15
Pravastatin Sodium	Pravastatin Sodium	54	15
Metoprolol Tartrate	Metoprolol Tartrate	52	17
Albuterol Sulfate Hfa	Albuterol Sulfate	50	22
Torsemide	Torsemide	49	18
Atenolol	Atenolol	48	12
Tizanidine Hcl	Tizanidine Hcl	48	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	45
Fluticasone Propionate	Fluticasone Propionate	47	21
Diazepam	Diazepam	46	suppressed
Tramadol Hcl	Tramadol Hcl	46	suppressed
Fluconazole	Fluconazole	44	31
Allopurinol	Allopurinol	43	14
Cephalexin	Cephalexin	42	36
Bupropion Xl	Bupropion Hcl	41	11
Vitamin D2	Ergocalciferol (Vitamin D2)	39	13
Eliquis	Apixaban	38	11
Ibuprofen	Ibuprofen	37	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	12
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Ondansetron Odt	Ondansetron	36	25
Donepezil Hcl	Donepezil Hcl	35	suppressed
Meclizine Hcl	Meclizine Hcl	35	12
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	34	suppressed
Cefdinir	Cefdinir	33	25
Linzess	Linaclotide	33	suppressed
Temazepam	Temazepam	33	suppressed
Carvedilol	Carvedilol	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Spironolactone	Spironolactone	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	20
Amoxicillin	Amoxicillin	28	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Ozempic	Semaglutide	27	suppressed
Mupirocin	Mupirocin	26	22
Celecoxib	Celecoxib	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Methocarbamol	Methocarbamol	24	16
Nifedipine Er	Nifedipine	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Levofloxacin	Levofloxacin	21	14
Perphenazine	Perphenazine	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Brilinta	Ticagrelor	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Estradiol	Estradiol	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Lamotrigine	Lamotrigine	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error